CarnoSyn beta-alanine recognized as safe

Natural Alternatives International, Inc Announces SR CarnoSyn® Receives GRAS Affirmation

CARLSBAD, Calif., April 11, 2017 — Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced the use of SR CarnoSyn® (sustained release beta-alanine, in a tablet or powder form) has been determined to be safe through independent scientific procedures, thus satisfying the technical element of the Generally Recognized as Safe (GRAS) determination. In addition, because this safety evaluation was based on generally available and widely accepted data and information, it also satisfies the so-called “common knowledge” element of a GRAS determination.

The new GRAS affirmation allows NAI to broaden their product offerings beyond the sports nutrition space and focus on the food and beverage industries including medical and other fortified food products. NAI can now aggressively pursue partnerships with key players in the healthy aging and food and beverage industries to provide unique SR CarnoSyn® product offerings to the specialty food category. SR CarnoSyn® is available exclusively from NAI.

Mark A. Le Doux, Chairman and Chief Executive Officer stated, “We are very pleased with the results of the safety evaluation of SR CarnoSyn® by a panel of independent experts. Over the last several years, NAI has made strategic investments in the areas of research and development, intellectual property, regulatory and commercialization surrounding our plans for current and future SR CarnoSyn® product offerings. The fact that the panel has finalized its scientific analysis and concluded that 12 grams of SR CarnoSyn®, which contains 7 grams of active CarnoSyn® beta-alanine, was well tolerated in human clinical trials, confirms our belief such dosage amounts are safe and effective. Satisfying these critical elements of GRAS determination allows us to continue to pursue several avenues for SR CarnoSyn® and collaborate with key partners in some of the fastest growing industries.”

NAI, headquartered in Carlsbad, California, is a leading formulator, manufacturer and marketer of nutritional supplements and provides strategic partnering services to its customers. Our comprehensive partnership approach offers a wide range of innovative nutritional products and services to our clients including: scientific research, clinical studies, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management and support, packaging and delivery system design, regulatory review and international product registration assistance. For more information about NAI, please see our website at

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934 that are not historical facts and information. These statements represent our intentions, expectations and beliefs concerning future events, including, among other things, our future revenue profits and financial condition, our ability to maintain our patents, generate revenues from the commercialization of our patents and trademarks, secure compliance with our intellectual property rights, and develop, maintain or increase sales to new and existing customers, as well as future economic conditions and the impact of such conditions on our business. We wish to caution readers these statements involve risks and uncertainties that could cause actual results and outcomes for future periods to differ materially from any forward-looking statement or views expressed herein. NAI’s financial performance and the forward-looking statements contained herein are further qualified by other risks including those set forth from time to time in the documents filed by us with the Securities and Exchange Commission, including our most recent Annual Report on Form 10-K.

CONTACT – Michael Fortin, Chief Financial Officer, Natural Alternatives International, Inc., at 760-736-7700 or [email protected].
Web site: